February 18, 2021
Oncopeptides Year-end Report 2020
Media
February 18, 2021
Targovax ASA: Annual Report 2020
February 18, 2021
Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma
February 18, 2021
Targovax ASA: Fourth quarter 2020 results
February 18, 2021
Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2020
February 17, 2021
BONESUPPORT HOLDING AB (publ) – Publishes Full year report 2020
February 16, 2021
Strongbridge Biopharma plc Announces Promotion of Richard S. Kollender to President and Chief Financial Officer
February 16, 2021
Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
February 15, 2021
Doctrin Launches Medical Questionnaires for Smoother Vaccination Flows
February 15, 2021
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2020 Results Presentation and Webcast